TP53 and thymic carcinoma: The most frequent SNV classified as homozygous or heterozygous in 50 of 53 (94%) TET patients (33 of 34 [97%] thymic carcinomas and 17 of 19 [89%] thymomas) was the TP53 p.(Pro72Arg) missense variant.